Loading...
•
Oct 02, 2021
Waters Q3 2021 Earnings Report
Waters reported an 11% increase in sales and a rise in both GAAP and non-GAAP EPS, driven by strong performance in the pharmaceutical and industrial end markets.
Key Takeaways
Waters Corporation reported Q3 2021 sales of $659 million, an 11% increase compared to Q3 2020. GAAP EPS increased to $2.60, and non-GAAP EPS increased to $2.66. The company saw strong growth in pharmaceutical and industrial end markets and balanced customer demand across the Americas, Europe, and Asia.
Sales of $659 million grew 11% as reported and in constant currency.
GAAP EPS of $2.60; non-GAAP EPS of $2.66, a 23% increase from prior year.
Growth was led by strong performance in pharmaceutical and industrial end markets.
There was double-digit growth in both instrument sales and recurring revenues.
Revenue by Geographic Location
Forward Guidance
The Company expects full-year 2021 constant-currency sales growth in the range of 15% to 16%. Currency translation is expected to increase full-year sales growth by approximately one percentage point. The Company expects full-year 2021 non-GAAP EPS in the range of $10.94 to $11.04. The Company expects fourth quarter 2021 constant-currency sales growth in the range of 5% to 7%. Currency translation is expected to decrease fourth quarter sales growth by approximately two percentage points. The Company expects fourth quarter 2021 non-GAAP EPS in the range of $3.40 to $3.50.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...